CSL BEHRING AG
Bern, CH
CSL BEHRING AG Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20150017181 | PREVENTION OF INFECTION - The invention relates to compositions and methods to prevent enteric infection in a subject at risk of such infection. In particular, the invention relates to the prevention of recurrence of infection by | 01-15-2015 |
20130302345 | CD89 ACTIVATION IN THERAPY - The invention relates to the use of CD89 activating molecules, in particular Fc alpha comprising molecules, and more particularly, IgA, for inducing apoptosis in neutrophils. Anti-CD89 antibodies can alternatively be used. The CD89 activation is beneficial in the treatment of various disorders associated with increases in neutrophils, such as autoimmune disorders, inflammatory disorders, NETosis, or cystic fibrosis. | 11-14-2013 |
20130102760 | Immunoglobulin Preparations Having Increased Stability - The present invention relates to a protein preparation having increased stability, comprising a stabiliser selected from the group consisting of non-polar and basic amino acids and having a pH of 4.0 to 5.2. The invention further relates to a pharmaceutical composition and a method of stabilising protein preparations. | 04-25-2013 |